ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,561Medicare Part D Prescriptions Filled, Including Refills

Rank: 96 out of 278

$534K Total Retail Price of All Prescriptions

Rank: 96 out of 278

437 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 6,784 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
LEVOTHYROXINE SODIUM 449 370 1 2
LISINOPRIL 381 299 2 5
OMEPRAZOLE 369 305 3 3
SIMVASTATIN 347 313 4 4
AMLODIPINE BESYLATE 230 224 5 7
FUROSEMIDE 223 173 6 6
PRAVASTATIN SODIUM 218 126 7 16
METOPROLOL TARTRATE 198 155 8 9
METOPROLOL SUCCINATE 193 141 9 10
CLONIDINE HCL 180 165 10 50
GLIMEPIRIDE 179 148 11 28
ATORVASTATIN CALCIUM 170 123 12 13
ZOLPIDEM TARTRATE 146 129 13 26
METFORMIN HCL 141 106 14 8
NEXIUM 129 83 15 14
ZETIA 110 70 16 59
FLUOXETINE HCL 104 77 17 68
SERTRALINE HCL 104 91 17 25
GABAPENTIN 102 79 19 12
ATENOLOL 99 96 20 18
HYDROCODONE-ACETAMINOPHEN 99 84 S3 20 1
LEVOFLOXACIN 88 64 22 66
MELOXICAM 84 68 23 37
FLUTICASONE PROPIONATE 83 50 24 44
DIOVAN 82 68 25 43
TRIAMTERENE-HCTZ 81 79 26 58
GLYBURIDE-METFORMIN HCL 80 69 R 27 159
KLOR-CON M20 80 76 27 42
DIGOXIN 78 74 29 40
CRESTOR 77 47 30 19
JANUVIA 73 48 31 53
GEMFIBROZIL 72 51 32 118
CLOPIDOGREL 71 65 33 20
SPIRONOLACTONE 68 50 34 62
LOSARTAN POTASSIUM 64 47 35 24
ALENDRONATE SODIUM 64 59 35 51
LIPITOR 63 48 37 127
PLAVIX 63 57 37 30
ADVAIR DISKUS 61 39 39 45
HYDROCHLOROTHIAZIDE 61 61 39 15
AMOX TR-POTASSIUM CLAVULANATE 59 47 41 129
HYDRALAZINE HCL 55 54 42 91
QUINAPRIL HCL 54 53 43 94
DONEPEZIL HCL 51 47 44 29
LOSARTAN-HYDROCHLOROTHIAZIDE 51 51 44 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.